These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 19013337)

  • 1. Sequential prescription of antifungals in invasive fungal infection: the importance of mechanism of action.
    Candel FJ; Matesanz M; Mensa J
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S133-5. PubMed ID: 19013337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Teaching old drugs new tricks: reincarnating immunosuppressants as antifungal drugs.
    Blankenship JR; Steinbach WJ; Perfect JR; Heitman J
    Curr Opin Investig Drugs; 2003 Feb; 4(2):192-9. PubMed ID: 12669381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Harnessing calcineurin as a novel anti-infective agent against invasive fungal infections.
    Steinbach WJ; Reedy JL; Cramer RA; Perfect JR; Heitman J
    Nat Rev Microbiol; 2007 Jun; 5(6):418-30. PubMed ID: 17505522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical practice: combination antifungal therapy for mold infections: much ado about nothing?
    Vazquez JA
    Clin Infect Dis; 2008 Jun; 46(12):1889-901. PubMed ID: 18466092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Newer antifungal agents for invasive fungal infections in patients with haematological malignancy.
    Rogers TR; Frost S
    Br J Haematol; 2009 Mar; 144(5):629-41. PubMed ID: 19120371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination treatment of invasive fungal infections.
    Mukherjee PK; Sheehan DJ; Hitchcock CA; Ghannoum MA
    Clin Microbiol Rev; 2005 Jan; 18(1):163-94. PubMed ID: 15653825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting virulence: a new paradigm for antifungals.
    Gauwerky K; Borelli C; Korting HC
    Drug Discov Today; 2009 Feb; 14(3-4):214-22. PubMed ID: 19152839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination antifungal therapy: the new frontier.
    Vazquez JA
    Future Microbiol; 2007 Apr; 2(2):115-39. PubMed ID: 17661650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunomodulatory properties of antifungal agents on phagocytic cells.
    Simitsopoulou M; Roilides E; Walsh TJ
    Immunol Invest; 2011; 40(7-8):809-24. PubMed ID: 21985307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antifungal combinations.
    Vitale RG; Afeltra J; Dannaoui E
    Methods Mol Med; 2005; 118():143-52. PubMed ID: 15888940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunocompromised hosts: immunopharmacology of modern antifungals.
    Ben-Ami R; Lewis RE; Kontoyiannis DP
    Clin Infect Dis; 2008 Jul; 47(2):226-35. PubMed ID: 18540822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salvage therapy trials in invasive fungal disease: challenges and opportunities.
    Powers JH
    Clin Infect Dis; 2006 Dec; 43(11):1456-60. PubMed ID: 17083021
    [No Abstract]   [Full Text] [Related]  

  • 13. Alternative treatment of fungal infections: Synergy with non-antifungal agents.
    Rossato L; Camargo Dos Santos M; Vitale RG; de Hoog S; Ishida K
    Mycoses; 2021 Mar; 64(3):232-244. PubMed ID: 33098146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical relevance of resistance to antifungals.
    Rodriguez-Tudela JL; Alcazar-Fuoli L; Cuesta I; Alastruey-Izquierdo A; Monzon A; Mellado E; Cuenca-Estrella M
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S111-3. PubMed ID: 19013333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phaeohyphomycosis in a tertiary care cancer center.
    Ben-Ami R; Lewis RE; Raad II; Kontoyiannis DP
    Clin Infect Dis; 2009 Apr; 48(8):1033-41. PubMed ID: 19267655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [How do fungal infections "escape" treatment? Resistance and resistance mechanisms].
    Morschhäuser J
    Pharm Unserer Zeit; 2003; 32(2):124-8. PubMed ID: 12677965
    [No Abstract]   [Full Text] [Related]  

  • 17. Recent approaches to antifungal therapy for invasive mycoses.
    Mathew BP; Nath M
    ChemMedChem; 2009 Mar; 4(3):310-23. PubMed ID: 19170067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in invasive fungal infections, with emphasis on invasive aspergillosis.
    Erjavec Z; Kluin-Nelemans H; Verweij PE
    Clin Microbiol Infect; 2009 Jul; 15(7):625-33. PubMed ID: 19673973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antifungal pharmacodynamics: review of the literature and clinical applications.
    Dodds ES; Drew RH; Perfect JR
    Pharmacotherapy; 2000 Nov; 20(11):1335-55. PubMed ID: 11079283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Present status of antimycotics.
    Kerridge D
    Microbiol Sci; 1985; 2(3):78, 83-6. PubMed ID: 3939997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.